HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
701	4129 Date I Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: Basic and clinical studies BRAIN RESEARCH BULLETIN. 1996; 40 (1): 1-19	6	26	29	221
702	7791 Boman J, Cosentini R, Blasi F, Saikku P, Bauriedel G, et al. Chronic diseases possibly associated with Chlamydia pneumoniae infections CHLAMYDIA PNEUMONIAE AND CHRONIC DISEASES. 2000; : 63-152	0	0	4	221
703	17808 Uversky VN, Kabanov AV, Lyubchenko YL Nanotools for megaproblems: Probing protein misfolding diseases using nanomedicine Modus operandi JOURNAL OF PROTEOME RESEARCH. 2006 OCT 6; 5 (10): 2505-2522	5	13	29	221
704	18011 Heneka MT Inflammation in Alzheimer's disease CLINICAL NEUROSCIENCE RESEARCH. 2006 DEC; 6 (5): 247-260	0	4	26	221
705	22469 Lisak RP, Benjamins JA, Bealmear B, Nedelkoska L, Studzinski D, et al. Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures JOURNAL OF NEUROINFLAMMATION. 2009 JAN 21; 6: Art. No. 4	0	7	8	221
706	22668 Savage MJ, Gingrich DE Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 125-144	2	5	78	221
707	22673 Bellon A, Le Pen G, Matricon J, Jay TM, Krebs MO Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia EXPERT OPINION ON DRUG DISCOVERY. 2009 MAR; 4 (3): 257-278	0	0	30	221
708	25103 Higuchi M, Maeda J, Ji B, Maruyama M, Okauchi T, et al. In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 APR; 1802 (4): 373-388	1	1	77	221
709	25675 Laureys G, Clinckers R, Gerlo S, Spooren A, Wilczak N, et al. Astrocytic beta(2)-adrenergic receptors: From physiology to pathology PROGRESS IN NEUROBIOLOGY. 2010 JUL; 91 (3): 189-199	0	0	5	221
710	4605 Price DL, Becher MW, Wong PC, Borchelt DR, Lee MK, et al. Inherited neurodegenerative diseases and transgenic models BRAIN PATHOLOGY. 1996 OCT; 6 (4): 467-480	3	5	17	220
#	Date / Author / Journal	LCS	GCS	LCR	CR
711	4761 Prusiner SB, Scott MR Genetics of prions ANNUAL REVIEW OF GENETICS. 1997; 31: 139-175	3	85	2	220
712	4777 Slooter AJC, vanDuijn CM Genetic epidemiology of Alzheimer disease EPIDEMIOLOGIC REVIEWS. 1997; 19 (1): 107-119	4	36	9	220
713	5317 Levant B The D-3 dopamine receptor: Neurobiology and potential clinical relevance PHARMACOLOGICAL REVIEWS. 1997 SEP; 49 (3): 231-252	0	274	2	220
714	10209 Cacabelos R Pharmacogenomics for the treatment of dementia ANNALS OF MEDICINE. 2002; 34 (5): 357-379	6	28	21	220
715	14426 Sarter M, Bruno JP Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities NEUROBIOLOGY OF AGING. 2004 OCT; 25 (9): 1127-1139	3	63	19	220
716	17562 Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 2006 SEP; 40 (9): 725-741	1	33	12	220
717	19929 Pankratz N, Foroud T Genetics of Parkinson disease GENETICS IN MEDICINE. 2007 DEC; 9 (12): 801-811	2	21	50	220
718	21171 van Tijn P, Hol EM, van Leeuwen FW, Fischer DF The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype PROGRESS IN NEUROBIOLOGY. 2008 JUN; 85 (2): 176-193	3	12	52	220
719	21674 Benes P, Vetvicka V, Fusek M Cathepsin D-Many functions of one aspartic protease CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2008 OCT; 68 (1): 12-28	1	34	5	220
720	24263 Lin YC, Koleske AJ Mechanisms of Synapse and Dendrite Maintenance and Their Disruption in Psychiatric and Neurodegenerative Disorders ANNUAL REVIEW OF NEUROSCIENCE, VOL 33. 2010; 33: 349-378	0	2	9	220
#	Date / Author / Journal	LCS	GCS	LCR	CR
721	25799 Uversky VN Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D-2 concept EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 543-564	0	1	36	220
722	26609 Calabrese V, Cornelius C, Stella AMG, Calabrese EJ Cellular Stress Responses, Mitostress and Carnitine Insufficiencies as Critical Determinants in Aging and Neurodegenerative Disorders: Role of Hormesis and Vitagenes NEUROCHEMICAL RESEARCH. 2010 DEC; 35 (12): 1880-1915	0	0	14	220
723	364 SWADLOW HA EFFERENT SYSTEMS OF PRIMARY VISUAL-CORTEX - A REVIEW OF STRUCTURE AND FUNCTION BRAIN RESEARCH REVIEWS. 1983; 6 (1): 1-24	6	49	14	219
724	919 SHAMMAHLAGNADO SJ, NEGRAO N, SILVA BA, RICARDO JA AFFERENT CONNECTIONS OF THE NUCLEI RETICULARIS PONTIS ORALIS AND CAUDALIS - A HORSERADISH-PEROXIDASE STUDY IN THE RAT NEUROSCIENCE. 1987 MAR; 20 (3): 961-989	1	87	15	219
725	1296 ERLANDSON RA CYTOSKELETAL PROTEINS INCLUDING MYOFILAMENTS IN HUMAN-TUMORS ULTRASTRUCTURAL PATHOLOGY. 1989; 13 (2-3): 155-186	1	8	14	219
726	2786 EIDE FF, LOWENSTEIN DH, REICHARDT LF NEUROTROPHINS AND THEIR RECEPTORS - CURRENT CONCEPTS AND IMPLICATIONS FOR NEUROLOGIC DISEASE EXPERIMENTAL NEUROLOGY. 1993 JUN; 121 (2): 200-214	9	172	14	219
727	5903 Jellinger KA Neuropathology of movement disorders NEUROSURGERY CLINICS OF NORTH AMERICA. 1998 APR; 9 (2): 237-+	10	17	26	219
728	10414 Kim SY, Jeitner TM, Steinert PM Transglutaminase in disease NEUROCHEMISTRY INTERNATIONAL. 2002 JAN; 40 (1): 85-103	4	94	25	219
729	12357 Dawbarn D, Allen SJ Neurotrophins and neurodegeneration NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 JUN; 29 (3): 211-230	7	73	21	219
730	20809 Hu YH, Russek SJ BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation JOURNAL OF NEUROCHEMISTRY. 2008 APR; 105 (1): 1-17	1	22	7	219
#	Date / Author / Journal	LCS	GCS	LCR	CR
731	24923 Wisniewski T, Boutajangout A Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 201-218	1	2	74	219
732	25445 Cheah BC, Vucic S, Krishnan AV, Kiernan MC Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis CURRENT MEDICINAL CHEMISTRY. 2010 JUN; 17 (18): 1942-1959	0	4	19	219
733	6215 McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, et al. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1998 AUG; 24 (4): 251-267	129	129	20	218
734	8340 Hrib NJ The dopamine D-4 receptor: a controversial therapeutic target DRUGS OF THE FUTURE. 2000 JUN; 25 (6): 587-611	0	31	3	218
735	12173 Tatton W, Chen D, Chalmers-Redman R, Wheeler L, Nixon R, et al. Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: Anti-apoptosis by alpha-2-adrenergic receptor activation SURVEY OF OPHTHALMOLOGY. 2003 APR; 48: S25-S37	3	23	19	218
736	14157 Vincent AM, Russell JW, Low P, Feldman EL Oxidative stress in the pathogenesis of diabetic neuropathy ENDOCRINE REVIEWS. 2004 AUG; 25 (4): 612-628	3	138	3	218
737	18444 Singh N, Pillay V, Choonara YE Advances in the treatment of Parkinson's disease PROGRESS IN NEUROBIOLOGY. 2007 JAN; 81 (1): 29-44	11	50	25	218
738	19356 Smith DG, Cappai R, Barnham KJ The redox chemistry of the Alzheimer's disease amyloid beta peptide BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2007 AUG; 1768 (8): 1976-1990	20	102	22	218
739	26789 Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, et al. Brain fuel metabolism, aging, and Alzheimer's disease NUTRITION. 2011 JAN; 27 (1): 3-20	1	2	13	218
740	472 GOULD HJ INTERHEMISPHERIC CONNECTIONS OF THE VISUAL-CORTEX IN THE GREY SQUIRREL (SCIURUS-CAROLINENSIS) JOURNAL OF COMPARATIVE NEUROLOGY. 1984; 223 (2): 259-301	5	27	26	217
#	Date / Author / Journal	LCS	GCS	LCR	CR
741	2589 TSIANG H PATHOPHYSIOLOGY OF RABIES VIRUS-INFECTION OF THE NERVOUS-SYSTEM ADVANCES IN VIRUS RESEARCH, VOL 42. 1993; 42: 375-412	4	38	6	217
742	5322 Starostina MV, Shtark MB Monoclonal antibodies in neurobiology VOPROSY MEDITSINSKOI KHIMII. 1997 SEP-OCT; 43 (5): 366-389	0	0	6	217
743	11674 Neumnaitis J Selective replicating viral vectors - Potential for use in cancer gene therapy BIODRUGS. 2003; 17 (4): 251-262	0	1	14	217
744	11876 Fowler JS, Ding YS, Volkow ND Radiotracers for positron emission tomography imaging SEMINARS IN NUCLEAR MEDICINE. 2003 JAN; 33 (1): 14-27	0	14	2	217
745	13406 Marien P, Paghera B, De Deyn PP, Vignolo LA Adult crossed aphasia in dextrals revisited CORTEX. 2004 FEB; 40 (1): 41-74	0	14	13	217
746	16437 Ono K, Naiki H, Yamada M The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fA beta), as well as destabilize preformed fA beta CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4357-4375	1	14	17	217
747	17344 Borek LL, Amick MM, Friedman JH Non-motor aspects of Parkinson's disease CNS SPECTRUMS. 2006 JUL; 11 (7): 541-554	0	11	12	217
748	18319 Dwyer DS, Dickson A Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries PHARMACOLOGY OF NEUROGENESIS AND NEUROENHANCEMENT. 2007; 77: 247-289	0	1	13	217
749	19133 Walton HS, Dodd PR Glutamate-glutamine cycling in Alzheimer's disease NEUROCHEMISTRY INTERNATIONAL. 2007 JUN; 50 (7-8): 1052-1066	2	17	18	217
750	23993 Wenning GK, Stefanova N Recent developments in multiple system atrophy JOURNAL OF NEUROLOGY. 2009 NOV; 256 (11): 1791-1808	5	5	45	217
#	Date / Author / Journal	LCS	GCS	LCR	CR
751	26335 Huang QA, Figueiredo-Pereira ME Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications APOPTOSIS. 2010 NOV; 15 (11): 1292-1311	0	2	47	217
752	4339 Spence P, Franco R, Wood A, Moyer JA Mechanisms of apoptosis as drug targets in the central nervous system EXPERT OPINION ON THERAPEUTIC PATENTS. 1996 APR; 6 (4): 345-366	0	3	3	216
753	6221 Turner DA, Buhl EH, Hailer NP, Nitsch R Morphological features of the entorhinal-hippocampal connection PROGRESS IN NEUROBIOLOGY. 1998 AUG; 55 (6): 537-562	4	47	5	216
754	7225 Foster GA, Stringer BMJ Genetic regulatory elements introduced into neural stem and progenitor cell populations BRAIN PATHOLOGY. 1999 JUL; 9 (3): 547-567	1	4	18	216
755	7859 Barbas H Complementary roles of prefrontal cortical regions in cognition, memory, and emotion in primates NEOCORTICAL EPILEPSIES. 2000; 84: 87-110	3	17	36	216
756	9437 Selkoe DJ Alzheimer's disease: Genes, proteins, and therapy PHYSIOLOGICAL REVIEWS. 2001 APR; 81 (2): 741-766	416	2136	35	216
757	10308 Browne SE, Beal MF Toxin-induced mitochondrial dysfunction MITOCHONDRIAL FUNCTION AND DYSFUNCTION. 2002; 53: 243-279	0	10	12	216
758	15183 Bennett MC The role of alpha-synuclein in neurodegenerative diseases PHARMACOLOGY & THERAPEUTICS. 2005 MAR; 105 (3): 311-331	42	67	156	216
759	23057 Marambaud P, Dreses-Werringloer U, Vingtdeux V Calcium signaling in neurodegeneration MOLECULAR NEURODEGENERATION. 2009 MAY 6; 4: Art. No. 20	3	12	22	216
760	23252 Iqbal K, Liu F, Gong CX, Alonso AD, Grundke-Iqbal I Mechanisms of tau-induced neurodegeneration ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 53-69	31	56	118	216
#	Date / Author / Journal	LCS	GCS	LCR	CR
761	6987 Collier TJ, Sortwell CE Therapeutic potential of nerve growth factors in Parkinson's disease DRUGS & AGING. 1999 APR; 14 (4): 261-287	13	33	14	215
762	11809 Otto M, Wiltfang J Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease RESTORATIVE NEUROLOGY AND NEUROSCIENCE. 2003; 21 (3-4): 191-209	3	9	36	215
763	14606 Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, et al. Neurofilament proteins in neurodegenerative diseases CELLULAR AND MOLECULAR LIFE SCIENCES. 2004 DEC; 61 (24): 3057-3075	12	41	103	215
764	20295 Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, et al. Word-finding difficulty: a clinical analysis of the progressive aphasias BRAIN. 2008 JAN; 131: 8-38	8	17	50	215
765	20608 Carvalho AL, Caldeira MV, Santos SD, Duarte CB Role of the brain-derived neurotrophic factor at glutamatergic synapses BRITISH JOURNAL OF PHARMACOLOGY. 2008 MAR; 153: S310-S324	1	41	3	215
766	21340 Robinson PA Protein stability and aggregation in Parkinson's disease BIOCHEMICAL JOURNAL. 2008 JUL 1; 413: 1-13	4	6	102	215
767	24391 Alves TCDF, Ferreira LK, Wajngarten M, Busatto GF Cardiac Disorders as Risk Factors for Alzheimer's Disease JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (3): 749-763	0	1	7	215
768	26176 Duan WZ, Ross CA Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction CURRENT DRUG TARGETS. 2010 OCT; 11 (10): 1281-1292	0	0	27	215
769	26325 Sangoi AR, Karamchandani J, Kim J, Pai RK, McKenney JK The Use of Immunohistochemistry in the Diagnosis of Metastatic Clear Cell Renal Cell Carcinoma A Review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10 ADVANCES IN ANATOMIC PATHOLOGY. 2010 NOV; 17 (6): 377-393	0	0	9	215
770	26572 Bekris LM, Mata IF, Zabetian CP The Genetics of Parkinson Disease JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2010 DEC; 23 (4): 228-242	0	0	85	215
#	Date / Author / Journal	LCS	GCS	LCR	CR
771	11316 Wrensch M, Minn Y, Chew T, Bondy M, Berger MS Epidemiology of primary brain tumors: Current concepts and review of the literature NEURO-ONCOLOGY. 2002 OCT; 4 (4): 278-299	5	182	2	214
772	18365 Frid P, Anisimov SV, Popovic N Congo red and protein aggregation in neurodegenerative diseases BRAIN RESEARCH REVIEWS. 2007 JAN; 53 (1): 135-160	12	50	34	214
773	26054 Shiroma PR, Geda YE, Mrazek DA Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry PHARMACOGENOMICS. 2010 SEP; 11 (9): 1305-1330	0	0	5	214
774	26241 Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ Astrocytes in Alzheimer's Disease NEUROTHERAPEUTICS. 2010 OCT; 7 (4): 399-412	0	0	21	214
775	3317 SMITH C, ANDERTON BH DOROTHY-RUSSELL-MEMORIAL-LECTURE - THE MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE - ARE WE ANY CLOSER TO UNDERSTANDING THE NEURODEGENERATIVE PROCESS NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1994 AUG; 20 (4): 322-338	11	28	56	213
776	4894 Aigner A, Wolf S, Gassen HG Transport and detoxication: Principles, approaches, and perspectives for research on the blood-brain barrier ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 1997 FEB 3; 36 (1-2): 25-41	1	1	2	213
777	5066 Billingsley ML, Kincaid RL Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration BIOCHEMICAL JOURNAL. 1997 MAY 1; 323: 577-591	118	200	129	213
778	7906 Mastrianni JA, Roos RP The prion diseases SEMINARS IN NEUROLOGY. 2000; 20 (3): 337-352	2	19	10	213
779	15394 Patenaude A, Murthy MRV, Mirault ME Emerging roles of thioredoxin cycle enzymes in the central nervous system CELLULAR AND MOLECULAR LIFE SCIENCES. 2005 MAY; 62 (10): 1063-1080	2	27	12	213
780	15796 Temel Y, Blokland A, Steinbusch HWM, Visser-Vandewalle V The functional role of the subthalamic nucleus in cognitive and limbic circuits PROGRESS IN NEUROBIOLOGY. 2005 AUG; 76 (6): 393-413	0	71	9	213
#	Date / Author / Journal	LCS	GCS	LCR	CR
781	16960 Xie ZC, Tanzi RE Alzheimer's disease and post-operative cognitive dysfunction EXPERIMENTAL GERONTOLOGY. 2006 APR; 41 (4): 346-359	7	29	19	213
782	17632 Pasinelli P, Brown RH Molecular biology of amyotrophic lateral sclerosis: insights from genetics NATURE REVIEWS NEUROSCIENCE. 2006 SEP; 7 (9): 710-723	81	261	28	213
783	20036 Strong MJ The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis AMYOTROPHIC LATERAL SCLEROSIS. 2008; 9 (6): 323-338	15	22	66	213
784	26157 Schwab C, Klegeris A, McGeer PL Inflammation in transgenic mouse models of neurodegenerative disorders BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 889-902	1	4	51	213
785	26894 Thomas MG, Loschi M, Desbats MA, Boccaccio GL RNA granules: The good, the bad and the ugly CELLULAR SIGNALLING. 2011 FEB; 23 (2): 324-334	0	0	12	213
786	126 VANESSEN DC VISUAL AREAS OF THE MAMMALIAN CEREBRAL-CORTEX ANNUAL REVIEW OF NEUROSCIENCE. 1979; 2: 227-263	17	211	6	212
787	400 DAMJANOV I, KNOWLES BB MONOCLONAL-ANTIBODIES AND TUMOR-ASSOCIATED ANTIGENS LABORATORY INVESTIGATION. 1983; 48 (5): 510-525	2	61	1	212
788	2612 JOYCE JN THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - LIMBIC INTERACTIONS WITH SEROTONIN AND NOREPINEPHRINE PSYCHOPHARMACOLOGY. 1993; 112 (1): S16-S34	8	43	4	212
789	4079 Wischik CM, Harrington CR, Mena R Molecular determinants of paired helical filament assembly and its therapeutic implications in Alzheimer's disease INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 299-338	2	2	59	212
790	7960 Ojika K, Mitake S, Tohdoh N, Appel SH, Otsuka Y, et al. Hippocampal cholinergic neurostimulating peptides (HCNP) PROGRESS IN NEUROBIOLOGY. 2000 JAN; 60 (1): 37-83	2	48	6	212
#	Date / Author / Journal	LCS	GCS	LCR	CR
791	11862 Bachurin SO Medicinal chemistry approaches for the treatment and prevention of Alzheimer disease MEDICINAL RESEARCH REVIEWS. 2003 JAN; 23 (1): 48-88	1	28	17	212
792	14755 Jones TB, McDaniel EE, Popovich PG Inflammatory-mediated injury and repair in the traumatically injured spinal cord CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (10): 1223-1236	1	55	8	212
793	19142 Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease PHARMACOLOGY & THERAPEUTICS. 2007 JUN; 114 (3): 327-344	2	17	111	212
794	25126 Pienaar IS, Dexter DT, Burkhard PR Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis EXPERT REVIEW OF PROTEOMICS. 2010 APR; 7 (2): 205-226	0	1	40	212
795	25247 Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease ACTA NEUROPATHOLOGICA. 2010 MAY; 119 (5): 523-541	0	4	57	212
796	26718 Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, et al. Editorial NeuroAIDS review AIDS. 2011 JAN; 25 (2): 123-141	0	0	10	212
797	26763 Harvey BK, Richie CT, Hoffer BJ, Airavaara M Transgenic animal models of neurodegeneration based on human genetic studies JOURNAL OF NEURAL TRANSMISSION. 2011 JAN; 118 (1): 27-45	0	0	71	212
798	3152 IACOPINO AM, QUINTERO EM, MILLER EK CALBINDIN-D-28K - A POTENTIAL NEUROPROTECTIVE PROTEIN NEURODEGENERATION. 1994 MAR; 3 (1): 1-20	7	75	3	211
799	3587 ARENDT T, BRUCKNER MK, BIGL V, MARCOVA L DENDRITIC REORGANIZATION IN THE BASAL FOREBRAIN UNDER DEGENERATIVE CONDITIONS AND ITS DEFECTS IN ALZHEIMERS-DISEASE .2. AGING, KORSAKOFFS DISEASE, PARKINSONS-DISEASE, AND ALZHEIMERS-DISEASE JOURNAL OF COMPARATIVE NEUROLOGY. 1995 JAN 9; 351 (2): 189-222	18	70	7	211
800	6497 Pollack IF, Bredel M, Erff M Application of signal transduction inhibition as a therapeutic strategy for central nervous system tumors PEDIATRIC NEUROSURGERY. 1998 NOV; 29 (5): 228-244	0	8	6	211

Date / Author / Journal

701

Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: Basic and clinical studies

BRAIN RESEARCH BULLETIN. 1996; 40 (1): 1-19

221

702

7791 Boman J, Cosentini R, Blasi F, Saikku P, Bauriedel G, et al.

Chronic diseases possibly associated with Chlamydia pneumoniae infections

CHLAMYDIA PNEUMONIAE AND CHRONIC DISEASES. 2000; : 63-152

221

703

17808 Uversky VN, Kabanov AV, Lyubchenko YL

Nanotools for megaproblems: Probing protein misfolding diseases using nanomedicine Modus operandi

JOURNAL OF PROTEOME RESEARCH. 2006 OCT 6; 5 (10): 2505-2522

221

704

18011 Heneka MT

Inflammation in Alzheimer's disease

CLINICAL NEUROSCIENCE RESEARCH. 2006 DEC; 6 (5): 247-260

221

705

22469 Lisak RP, Benjamins JA, Bealmear B, Nedelkoska L, Studzinski D, et al.

Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures

JOURNAL OF NEUROINFLAMMATION. 2009 JAN 21; 6: Art. No. 4

221

706

22668 Savage MJ, Gingrich DE

Advances in the Development of Kinase Inhibitor Therapeutics for Alzheimer's Disease

DRUG DEVELOPMENT RESEARCH. 2009 MAR; 70 (2): 125-144

221

707

22673 Bellon A, Le Pen G, Matricon J, Jay TM, Krebs MO

Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia

EXPERT OPINION ON DRUG DISCOVERY. 2009 MAR; 4 (3): 257-278

221

708

25103 Higuchi M, Maeda J, Ji B, Maruyama M, Okauchi T, et al.

In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 APR; 1802 (4): 373-388

221

709

25675 Laureys G, Clinckers R, Gerlo S, Spooren A, Wilczak N, et al.

Astrocytic beta(2)-adrenergic receptors: From physiology to pathology

PROGRESS IN NEUROBIOLOGY. 2010 JUL; 91 (3): 189-199

221

710

4605 Price DL, Becher MW, Wong PC, Borchelt DR, Lee MK, et al.

Inherited neurodegenerative diseases and transgenic models

BRAIN PATHOLOGY. 1996 OCT; 6 (4): 467-480

220

Date / Author / Journal

LCS

GCS

LCR

711

4761 Prusiner SB, Scott MR

Genetics of prions

ANNUAL REVIEW OF GENETICS. 1997; 31: 139-175

220

712

4777 Slooter AJC, vanDuijn CM

Genetic epidemiology of Alzheimer disease

EPIDEMIOLOGIC REVIEWS. 1997; 19 (1): 107-119

220

713

5317 Levant B

The D-3 dopamine receptor: Neurobiology and potential clinical relevance

PHARMACOLOGICAL REVIEWS. 1997 SEP; 49 (3): 231-252

274

220

714

10209 Cacabelos R

Pharmacogenomics for the treatment of dementia

ANNALS OF MEDICINE. 2002; 34 (5): 357-379

220

715

14426 Sarter M, Bruno JP

Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities

NEUROBIOLOGY OF AGING. 2004 OCT; 25 (9): 1127-1139

220

716

17562 Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, et al.

Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. 2006 SEP; 40 (9): 725-741

220

717

19929 Pankratz N, Foroud T

Genetics of Parkinson disease

GENETICS IN MEDICINE. 2007 DEC; 9 (12): 801-811

220

718

21171 van Tijn P, Hol EM, van Leeuwen FW, Fischer DF

The neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype

PROGRESS IN NEUROBIOLOGY. 2008 JUN; 85 (2): 176-193

220

719

21674 Benes P, Vetvicka V, Fusek M

Cathepsin D-Many functions of one aspartic protease

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 2008 OCT; 68 (1): 12-28

220

720

24263 Lin YC, Koleske AJ

Mechanisms of Synapse and Dendrite Maintenance and Their Disruption in Psychiatric and Neurodegenerative Disorders

ANNUAL REVIEW OF NEUROSCIENCE, VOL 33. 2010; 33: 349-378

220

Date / Author / Journal

721

Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D-2 concept

EXPERT REVIEW OF PROTEOMICS. 2010 AUG; 7 (4): 543-564

220

722

26609 Calabrese V, Cornelius C, Stella AMG, Calabrese EJ

Cellular Stress Responses, Mitostress and Carnitine Insufficiencies as Critical Determinants in Aging and Neurodegenerative Disorders: Role of Hormesis and Vitagenes

NEUROCHEMICAL RESEARCH. 2010 DEC; 35 (12): 1880-1915

220

723

364 SWADLOW HA

EFFERENT SYSTEMS OF PRIMARY VISUAL-CORTEX - A REVIEW OF STRUCTURE AND FUNCTION

BRAIN RESEARCH REVIEWS. 1983; 6 (1): 1-24

219

724

919 SHAMMAHLAGNADO SJ, NEGRAO N, SILVA BA, RICARDO JA

AFFERENT CONNECTIONS OF THE NUCLEI RETICULARIS PONTIS ORALIS AND CAUDALIS - A HORSERADISH-PEROXIDASE STUDY IN THE RAT

NEUROSCIENCE. 1987 MAR; 20 (3): 961-989

219

725

1296 ERLANDSON RA

CYTOSKELETAL PROTEINS INCLUDING MYOFILAMENTS IN HUMAN-TUMORS

ULTRASTRUCTURAL PATHOLOGY. 1989; 13 (2-3): 155-186

219

726

2786 EIDE FF, LOWENSTEIN DH, REICHARDT LF

NEUROTROPHINS AND THEIR RECEPTORS - CURRENT CONCEPTS AND IMPLICATIONS FOR NEUROLOGIC DISEASE

EXPERIMENTAL NEUROLOGY. 1993 JUN; 121 (2): 200-214

172

219

727

5903 Jellinger KA

Neuropathology of movement disorders

NEUROSURGERY CLINICS OF NORTH AMERICA. 1998 APR; 9 (2): 237-+

219

728

10414 Kim SY, Jeitner TM, Steinert PM

Transglutaminase in disease

NEUROCHEMISTRY INTERNATIONAL. 2002 JAN; 40 (1): 85-103

219

729

12357 Dawbarn D, Allen SJ

Neurotrophins and neurodegeneration

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2003 JUN; 29 (3): 211-230

219

730

20809 Hu YH, Russek SJ

BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation

JOURNAL OF NEUROCHEMISTRY. 2008 APR; 105 (1): 1-17

219

Date / Author / Journal

LCS

GCS

LCR

731

24923 Wisniewski T, Boutajangout A

Immunotherapeutic approaches for Alzheimer's disease in transgenic mouse models

BRAIN STRUCTURE & FUNCTION. 2010 MAR; 214 (2-3): 201-218

219

732

25445 Cheah BC, Vucic S, Krishnan AV, Kiernan MC

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

CURRENT MEDICINAL CHEMISTRY. 2010 JUN; 17 (18): 1942-1959

219

733

6215 McIntosh TK, Saatman KE, Raghupathi R, Graham DI, Smith DH, et al.

The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1998 AUG; 24 (4): 251-267

129

218

734

8340 Hrib NJ

The dopamine D-4 receptor: a controversial therapeutic target

DRUGS OF THE FUTURE. 2000 JUN; 25 (6): 587-611

218

735

12173 Tatton W, Chen D, Chalmers-Redman R, Wheeler L, Nixon R, et al.

Hypothesis for a common basis for neuroprotection in glaucoma and Alzheimer's disease: Anti-apoptosis by alpha-2-adrenergic receptor activation

SURVEY OF OPHTHALMOLOGY. 2003 APR; 48: S25-S37

218

736

14157 Vincent AM, Russell JW, Low P, Feldman EL

Oxidative stress in the pathogenesis of diabetic neuropathy

ENDOCRINE REVIEWS. 2004 AUG; 25 (4): 612-628

138

218

737

18444 Singh N, Pillay V, Choonara YE

Advances in the treatment of Parkinson's disease

PROGRESS IN NEUROBIOLOGY. 2007 JAN; 81 (1): 29-44

218

738

19356 Smith DG, Cappai R, Barnham KJ

The redox chemistry of the Alzheimer's disease amyloid beta peptide

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES. 2007 AUG; 1768 (8): 1976-1990

102

218

739

26789 Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, et al.

Brain fuel metabolism, aging, and Alzheimer's disease

NUTRITION. 2011 JAN; 27 (1): 3-20

218

740

472 GOULD HJ

INTERHEMISPHERIC CONNECTIONS OF THE VISUAL-CORTEX IN THE GREY SQUIRREL (SCIURUS-CAROLINENSIS)

JOURNAL OF COMPARATIVE NEUROLOGY. 1984; 223 (2): 259-301

217

Date / Author / Journal

741

PATHOPHYSIOLOGY OF RABIES VIRUS-INFECTION OF THE NERVOUS-SYSTEM

ADVANCES IN VIRUS RESEARCH, VOL 42. 1993; 42: 375-412

217

742

5322 Starostina MV, Shtark MB

Monoclonal antibodies in neurobiology

VOPROSY MEDITSINSKOI KHIMII. 1997 SEP-OCT; 43 (5): 366-389

217

743

11674 Neumnaitis J

Selective replicating viral vectors - Potential for use in cancer gene therapy

BIODRUGS. 2003; 17 (4): 251-262

217

744

11876 Fowler JS, Ding YS, Volkow ND

Radiotracers for positron emission tomography imaging

SEMINARS IN NUCLEAR MEDICINE. 2003 JAN; 33 (1): 14-27

217

745

13406 Marien P, Paghera B, De Deyn PP, Vignolo LA

Adult crossed aphasia in dextrals revisited

CORTEX. 2004 FEB; 40 (1): 41-74

217

746

16437 Ono K, Naiki H, Yamada M

The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fA beta), as well as destabilize preformed fA beta

CURRENT PHARMACEUTICAL DESIGN. 2006; 12 (33): 4357-4375

217

747

17344 Borek LL, Amick MM, Friedman JH

Non-motor aspects of Parkinson's disease

CNS SPECTRUMS. 2006 JUL; 11 (7): 541-554

217

748

18319 Dwyer DS, Dickson A

Neuroprotection and enhancement of neurite outgrowth with small molecular weight compounds from screens of chemical libraries

PHARMACOLOGY OF NEUROGENESIS AND NEUROENHANCEMENT. 2007; 77: 247-289

217

749

19133 Walton HS, Dodd PR

Glutamate-glutamine cycling in Alzheimer's disease

NEUROCHEMISTRY INTERNATIONAL. 2007 JUN; 50 (7-8): 1052-1066

217

750

23993 Wenning GK, Stefanova N

Recent developments in multiple system atrophy

JOURNAL OF NEUROLOGY. 2009 NOV; 256 (11): 1791-1808

217

Date / Author / Journal

LCS

GCS

LCR

751

26335 Huang QA, Figueiredo-Pereira ME

Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications

APOPTOSIS. 2010 NOV; 15 (11): 1292-1311

217

752

4339 Spence P, Franco R, Wood A, Moyer JA

Mechanisms of apoptosis as drug targets in the central nervous system

EXPERT OPINION ON THERAPEUTIC PATENTS. 1996 APR; 6 (4): 345-366

216

753

6221 Turner DA, Buhl EH, Hailer NP, Nitsch R

Morphological features of the entorhinal-hippocampal connection

PROGRESS IN NEUROBIOLOGY. 1998 AUG; 55 (6): 537-562

216

754

7225 Foster GA, Stringer BMJ

Genetic regulatory elements introduced into neural stem and progenitor cell populations

BRAIN PATHOLOGY. 1999 JUL; 9 (3): 547-567

216

755

7859 Barbas H

Complementary roles of prefrontal cortical regions in cognition, memory, and emotion in primates

NEOCORTICAL EPILEPSIES. 2000; 84: 87-110

216

756

9437 Selkoe DJ

Alzheimer's disease: Genes, proteins, and therapy

PHYSIOLOGICAL REVIEWS. 2001 APR; 81 (2): 741-766

416

2136

216

757

10308 Browne SE, Beal MF

Toxin-induced mitochondrial dysfunction

MITOCHONDRIAL FUNCTION AND DYSFUNCTION. 2002; 53: 243-279

216

758

15183 Bennett MC

The role of alpha-synuclein in neurodegenerative diseases

PHARMACOLOGY & THERAPEUTICS. 2005 MAR; 105 (3): 311-331

156

216

759

23057 Marambaud P, Dreses-Werringloer U, Vingtdeux V

Calcium signaling in neurodegeneration

MOLECULAR NEURODEGENERATION. 2009 MAY 6; 4: Art. No. 20

216

760

23252 Iqbal K, Liu F, Gong CX, Alonso AD, Grundke-Iqbal I

Mechanisms of tau-induced neurodegeneration

ACTA NEUROPATHOLOGICA. 2009 JUL; 118 (1): 53-69

118

216

Date / Author / Journal

LCS

GCS

LCR

761

6987 Collier TJ, Sortwell CE

Therapeutic potential of nerve growth factors in Parkinson's disease

DRUGS & AGING. 1999 APR; 14 (4): 261-287

215

762

11809 Otto M, Wiltfang J

Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease

RESTORATIVE NEUROLOGY AND NEUROSCIENCE. 2003; 21 (3-4): 191-209

215

763

14606 Liu Q, Xie F, Siedlak SL, Nunomura A, Honda K, et al.

Neurofilament proteins in neurodegenerative diseases

CELLULAR AND MOLECULAR LIFE SCIENCES. 2004 DEC; 61 (24): 3057-3075

103

215

764

20295 Rohrer JD, Knight WD, Warren JE, Fox NC, Rossor MN, et al.

Word-finding difficulty: a clinical analysis of the progressive aphasias

BRAIN. 2008 JAN; 131: 8-38

215

765

20608 Carvalho AL, Caldeira MV, Santos SD, Duarte CB

Role of the brain-derived neurotrophic factor at glutamatergic synapses

BRITISH JOURNAL OF PHARMACOLOGY. 2008 MAR; 153: S310-S324

215

766

21340 Robinson PA

Protein stability and aggregation in Parkinson's disease

BIOCHEMICAL JOURNAL. 2008 JUL 1; 413: 1-13

102

215

767

24391 Alves TCDF, Ferreira LK, Wajngarten M, Busatto GF

Cardiac Disorders as Risk Factors for Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (3): 749-763

215

768

26176 Duan WZ, Ross CA

Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction

CURRENT DRUG TARGETS. 2010 OCT; 11 (10): 1281-1292

215

769

26325 Sangoi AR, Karamchandani J, Kim J, Pai RK, McKenney JK

The Use of Immunohistochemistry in the Diagnosis of Metastatic Clear Cell Renal Cell Carcinoma A Review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10

ADVANCES IN ANATOMIC PATHOLOGY. 2010 NOV; 17 (6): 377-393

215

770

26572 Bekris LM, Mata IF, Zabetian CP

The Genetics of Parkinson Disease

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2010 DEC; 23 (4): 228-242

215

Date / Author / Journal

LCS

GCS

LCR

771

11316 Wrensch M, Minn Y, Chew T, Bondy M, Berger MS

Epidemiology of primary brain tumors: Current concepts and review of the literature

NEURO-ONCOLOGY. 2002 OCT; 4 (4): 278-299

182

214

772

18365 Frid P, Anisimov SV, Popovic N

Congo red and protein aggregation in neurodegenerative diseases

BRAIN RESEARCH REVIEWS. 2007 JAN; 53 (1): 135-160

214

773

26054 Shiroma PR, Geda YE, Mrazek DA

Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry

PHARMACOGENOMICS. 2010 SEP; 11 (9): 1305-1330

214

774

26241 Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ

Astrocytes in Alzheimer's Disease

NEUROTHERAPEUTICS. 2010 OCT; 7 (4): 399-412

214

775

3317 SMITH C, ANDERTON BH

DOROTHY-RUSSELL-MEMORIAL-LECTURE - THE MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE - ARE WE ANY CLOSER TO UNDERSTANDING THE NEURODEGENERATIVE PROCESS

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 1994 AUG; 20 (4): 322-338

213

776

4894 Aigner A, Wolf S, Gassen HG

Transport and detoxication: Principles, approaches, and perspectives for research on the blood-brain barrier

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 1997 FEB 3; 36 (1-2): 25-41

213

777

5066 Billingsley ML, Kincaid RL

Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration

BIOCHEMICAL JOURNAL. 1997 MAY 1; 323: 577-591

118

200

129

213

778

7906 Mastrianni JA, Roos RP

The prion diseases

SEMINARS IN NEUROLOGY. 2000; 20 (3): 337-352

213

779

15394 Patenaude A, Murthy MRV, Mirault ME

Emerging roles of thioredoxin cycle enzymes in the central nervous system

CELLULAR AND MOLECULAR LIFE SCIENCES. 2005 MAY; 62 (10): 1063-1080

213

780

15796 Temel Y, Blokland A, Steinbusch HWM, Visser-Vandewalle V

The functional role of the subthalamic nucleus in cognitive and limbic circuits

PROGRESS IN NEUROBIOLOGY. 2005 AUG; 76 (6): 393-413

213

Date / Author / Journal

LCS

GCS

LCR

781

16960 Xie ZC, Tanzi RE

Alzheimer's disease and post-operative cognitive dysfunction

EXPERIMENTAL GERONTOLOGY. 2006 APR; 41 (4): 346-359

213

782

17632 Pasinelli P, Brown RH

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

NATURE REVIEWS NEUROSCIENCE. 2006 SEP; 7 (9): 710-723

261

213

783

20036 Strong MJ

The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis

AMYOTROPHIC LATERAL SCLEROSIS. 2008; 9 (6): 323-338

213

784

26157 Schwab C, Klegeris A, McGeer PL

Inflammation in transgenic mouse models of neurodegenerative disorders

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2010 OCT; 1802 (10): 889-902

213

785

26894 Thomas MG, Loschi M, Desbats MA, Boccaccio GL

RNA granules: The good, the bad and the ugly

CELLULAR SIGNALLING. 2011 FEB; 23 (2): 324-334

213

786

126 VANESSEN DC

VISUAL AREAS OF THE MAMMALIAN CEREBRAL-CORTEX

ANNUAL REVIEW OF NEUROSCIENCE. 1979; 2: 227-263

211

212

787

400 DAMJANOV I, KNOWLES BB

MONOCLONAL-ANTIBODIES AND TUMOR-ASSOCIATED ANTIGENS

LABORATORY INVESTIGATION. 1983; 48 (5): 510-525

212

788

2612 JOYCE JN

THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - LIMBIC INTERACTIONS WITH SEROTONIN AND NOREPINEPHRINE

PSYCHOPHARMACOLOGY. 1993; 112 (1): S16-S34

212

789

4079 Wischik CM, Harrington CR, Mena R

Molecular determinants of paired helical filament assembly and its therapeutic implications in Alzheimer's disease

INTERNATIONAL REVIEW OF PSYCHIATRY. 1995 DEC; 7 (3-4): 299-338

212

790

7960 Ojika K, Mitake S, Tohdoh N, Appel SH, Otsuka Y, et al.

Hippocampal cholinergic neurostimulating peptides (HCNP)

PROGRESS IN NEUROBIOLOGY. 2000 JAN; 60 (1): 37-83

212

Date / Author / Journal

791

Medicinal chemistry approaches for the treatment and prevention of Alzheimer disease

MEDICINAL RESEARCH REVIEWS. 2003 JAN; 23 (1): 48-88

212

792

14755 Jones TB, McDaniel EE, Popovich PG

Inflammatory-mediated injury and repair in the traumatically injured spinal cord

CURRENT PHARMACEUTICAL DESIGN. 2005; 11 (10): 1223-1236

212

793

19142 Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG

Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease

PHARMACOLOGY & THERAPEUTICS. 2007 JUN; 114 (3): 327-344

111

212

794

25126 Pienaar IS, Dexter DT, Burkhard PR

Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis

EXPERT REVIEW OF PROTEOMICS. 2010 APR; 7 (2): 205-226

212

795

25247 Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E

Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease

ACTA NEUROPATHOLOGICA. 2010 MAY; 119 (5): 523-541

212

796

26718 Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, et al.

Editorial NeuroAIDS review

AIDS. 2011 JAN; 25 (2): 123-141

212

797

26763 Harvey BK, Richie CT, Hoffer BJ, Airavaara M

Transgenic animal models of neurodegeneration based on human genetic studies

JOURNAL OF NEURAL TRANSMISSION. 2011 JAN; 118 (1): 27-45

212

798

3152 IACOPINO AM, QUINTERO EM, MILLER EK

CALBINDIN-D-28K - A POTENTIAL NEUROPROTECTIVE PROTEIN

NEURODEGENERATION. 1994 MAR; 3 (1): 1-20

211

799

3587 ARENDT T, BRUCKNER MK, BIGL V, MARCOVA L

DENDRITIC REORGANIZATION IN THE BASAL FOREBRAIN UNDER DEGENERATIVE CONDITIONS AND ITS DEFECTS IN ALZHEIMERS-DISEASE .2. AGING, KORSAKOFFS DISEASE, PARKINSONS-DISEASE, AND ALZHEIMERS-DISEASE

JOURNAL OF COMPARATIVE NEUROLOGY. 1995 JAN 9; 351 (2): 189-222

211

800

6497 Pollack IF, Bredel M, Erff M

Application of signal transduction inhibition as a therapeutic strategy for central nervous system tumors

PEDIATRIC NEUROSURGERY. 1998 NOV; 29 (5): 228-244

211

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records